Samuel Docena
Family Medicine · Fairfield, OHNPI 1376600973
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 239 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 15.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,113 and has fallen 82.5% since, to $194 in 2022.
Across 239 payments — averaging $14.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$528
- Merck$513
- Johnson & Johnson$461
- Novo Nordisk$318
- Amarin Pharma, Inc.$233
- Otsuka America Pharmaceutical, Inc.$202
- plus $1K from 21 others
What the payments were for
- Food & beverage$3,383100%
- Education$110%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 35 | $528 |
| Merck | 42 | $513 |
| Johnson & Johnson | 37 | $461 |
| Novo Nordisk | 20 | $318 |
| Amarin Pharma, Inc. | 15 | $233 |
| Otsuka America Pharmaceutical, Inc. | 12 | $202 |
| GSK | 16 | $201 |
| Lilly USA, LLC | 7 | $112 |
| AbbVie(2 entities) | 8 | $105 |
| Pfizer | 7 | $103 |
| Sanofi-aventis U.S. LLC | 7 | $97 |
| Amgen(2 entities) | 5 | $67 |
| Bayer | 3 | $63 |
| Abbott | 3 | $57 |
| Boehringer Ingelheim | 3 | $49 |
| Esperion Therapeutics, Inc. | 3 | $40 |
| Kowa Pharmaceuticals America, Inc. | 3 | $37 |
| Mannkind Corporation | 2 | $34 |
| Novartis | 2 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $22 |
| Eisai Inc. | 1 | $21 |
| Alk-abello, Inc | 1 | $20 |
| Dexcom, Inc. | 1 | $19 |
| Astellas Pharma US Inc | 1 | $19 |
| Melinta Therapeutics, LLC | 1 | $17 |
| Nabriva Therapeutics, PLC | 1 | $13 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $11 |
How this compares
$3,394 in reported general payments places this provider in the 80th percentile of 3,983 family medicine providers in Ohio.
Other family medicine in Fairfield
- Kwabena OtengSpringdale$2M
- Brian BeesleyColumbus$1.4M
- Darshana PatelBeachwood$648K
- Thomas GraceFindlay$503K
- Susan RatayAshtabula$379K
- Shannon TrotterSpringfield$348K
- Michael HeileCincinnati$272K
- Bradley EverlyMaumee$266K
- Tricia BedrickCuyahoga Falls$259K
- David NeidhardtLima$248K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.